#GU15 - Poster: External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the ALSYMPCA trial

ORLANDO, FL, USA (UroToday.com) - Presented by Stephen E. Finkelstein, Jeff M. Michalski, Joe M. O’Sullivan, Chris Parker, Jose E. Garcia-Vargas, and A. Oliver Sartor at the 2015 Genitourinary Cancers Symposium - "Integrating Biology Into Patient-Centric Care" - February 26 - 28, 2015 - Rosen Shingle Creek - Orlando, Florida USA

gu cancers 2015 finkelstein poster

21st Century Oncology, Scottsdale, AZ, USA; Washington University School of Medicine, St Louis, MO, USA; Centre for Cancer Research and Cell Biology, Queen’s University, Belfast, UK; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK; Bayer HealthCare, Whippany, NJ, USA; Tulane Cancer Center, New Orleans, LA, USA

Click HERE to read related content